National Poster Prize Winners

NP-005

IMPLEMENTING MEDICATION RECONCILIATION ON HOSPITAL ADMISSION: A MULTICENTER PILOT STUDY IN ESTONIA AND FINLAND (submitted in 2019)

NP-004

INITIATION OF A CLINICAL PHARMACIST LED, PROSPECTIVE AUDIT ON ANTIBIOTIC PRESCRIBING (submitted in 2019)

NP-003

STEADY-STATE PHARMACOKINETICS AND EARLY SAFETY DATA IN HIV-INFECTED AFRICAN CHILDREN WEIGHING ≥25KG AFTER SWITCHING TO 50MG FILM-COATED DOLUTEGRAVIR TABLETS IN THE ODYSSEY TRIAL (submitted in 2019)

NP-002

MEDICATION SAFETY IN PATIENTS TREATED WITH ORAL ANTITUMOR AGENTS: A PROSPECTIVE, RANDOMIZED INVESTIGATION TO IMPROVE PATIENT SAFETY AND WELL-BEING BY INTENSIFIED CLINICAL PHARMACEUTICAL/ PHARMACOLOGICAL CARE (submitted in 2019)

NP-001

IMPACT OF AN ORAL NUTRITION PROTOCOL IN PATIENTS TREATED WITH ELECTIVE RADICAL CYSTECTOMY: A LONG TERM FOLLOW-UP (submitted in 2019)

NP-014

DEVELOPMENT OF NEW PRODUCTION WHEN NEITHER PACKAGING NOR SOME OF THE RAW MATERIALS CONFORM TO EUROPEAN STANDARDS

NP-013

IMPLEMENTING THE EUROPEAN STATEMENTS OF HOSPITAL PHARMACY IN ITALY: RESULTS OF A WORKING GROUP

NP-012

STANDARDISATION OF ANALGESIA AND SEDATION INFUSION SOLUTIONS IN PAEDIATRIC PALLIATIVE PATIENTS RECEIVING END-OF-LIFE CARE AT HOME

NP-011

MEDISCREEN: IMPLEMENTATION OF A TOOL FOR DETECTING PATIENTS AT RISK OF ADVERSE DRUG EVENTS VIA THE ELECTRONIC MEDICAL RECORD

NP-010

WHAT IS THE EFFECT OF INTERPROFESSIONAL STUDENT PLACEMENTS IN PRIMARY CARE? A RETROSPECTIVE PRE-POST STUDY

NP-009

PATIENTS’ PERSONAL TREATMENT MANAGEMENT IN A UNIVERSITY HOSPITAL

NP-008

STABILITY OF CEFTOLOZANE/TAZOBACTAM IN SOLUTION AS INFUSION FOR PROLONGED OR CONTINUOUS APPLICATION

NP-007

MEDICATION ANALYSIS FOR HOSPITAL PATIENTS WITH RENAL INSUFFICIENCY: FROM DEVELOPMENT PHASE TO STANDARD PRACTICE

NP-006

EARLY DETECTION OF RETINOPATHY IN PREMATURE INFANTS USING MIXTURE OF EYE DROPS WITH 2.5% PHENYLEPHRINE HYDROCHLORIDE AND 0.5% TROPICAMIDE

NP-005

ESTIMATING RENAL FUNCTION FOR DRUG DOSING: EQUATIONS MATTER

Pages